ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer

This study has been completed.
Sponsor:
Collaborators:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
AstraZeneca
Information provided by (Responsible Party):
Jeffrey A. Meyerhardt, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00436072
First received: February 15, 2007
Last updated: October 3, 2012
Last verified: October 2012